AlphAIAlphAI — Financial news for AI agents
SEC EDGAR$SCND

MOORE JOHN A purchased $6K of SCND

MOORE JOHN A (Chairman of the Board) purchased 10,000 shares of SCIENTIFIC INDUSTRIES INC (SCND) at $0.60 on 2026-11-05.

Original reporting
SEC EDGAR · MOORE JOHN A
Published Nov 5, 2026, 10:09 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 5, 2026, 10:11 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
AlphAI market briefInsider activity
Primary signal
$SCND
Neutral
high confidence
Mentioned
$SCND
Relevance
4/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$SCNDNeutralLow
01

Why it matters

The filing adds a new data point on insider activity for SCND but is too small to drive market moves.

02

Market read

Minor insider purchase with limited trading relevance.

03

What to watch

Potential upcoming corporate actions or financing needs not disclosed in the filing.

Relevance 4/10Novelty 4/10Timing: filing today

Background

SEC Form 4 filings provide the first public disclosure of insider trades, offering transparency into insider sentiment.

Company-level read

Ticker impact

$SCNDNeutralHigh confidence
Context

Chairman John A. Moore purchased 10,000 shares of Scientific Industries Inc (SCND) for $6,000 via an open‑market Form 4 filing.

Expected impact

minimal upward pressure as market digests the modest buy.

Evidence & confidence

The transaction is under $10 k and represents a tiny fraction of total shares outstanding, so any price effect will be limited.

Market effects

Sector

None significant; insider activity does not alter sector outlook.

Regional

No regional impact.

Global

Limited to SCND shareholders.

Counterpoint

What could challenge this read

The purchase could be a routine portfolio rebalancing rather than a strong endorsement.

Key entities

  • Individual
    John A. Moore

    Chairman of the Board of Scientific Industries Inc.

Read at source← All news

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

SCND insider trading history →

Related articles

$LYELMedAI 8/10

ARCH Venture Fund XIII, L.P. (CRANDELL KEITH, GILLIS STEVEN) purchased $25.0M of LYEL (indirect holdings)

ARCH Venture Fund XIII, L.P. purchased 2,321,262 indirectly-held shares of Lyell Immunopharma, Inc. (LYEL) at $10.77 ($25.00M total) on 2026-11-04. Filed jointly with ARCH Venture Partners XIII, L.P. (10% owner), ARCH Venture Partners XIII, LLC (10% owner), CRANDELL KEITH (10% owner), GILLIS STEVEN (10% owner), NELSEN ROBERT (10% owner), Burow Kristina (10% owner), BERNS PAUL L (10% owner) and BYBEE CLINTON (10% owner).

SEC EDGAR